(Fighting New Coronary Pneumonia) Zhang Wenhong: China's rapid response and dynamic clearing strategy can cope with various new crown variants
China News Agency, Shanghai, November 28 (Reporter Chen Jing) The landing of the new variant of the new crown, Omi Keron, has aroused widespread concern.
Zhang Wenhong, head of the Shanghai New Coronary Pneumonia Clinical Treatment Expert Team and Director of the Department of Infectious Diseases at Huashan Hospital Affiliated to Fudan University, said on Weibo on the 28th, “This time the emergence of the mutant virus in South Africa is accidental, but will it be vulnerable to the current initial establishment? Population immunity poses a threat, and it takes about two weeks of observation time."
He pointed out that the new mutant strains will not have a big impact on China at present.
China's current rapid response and dynamic reset strategy can cope with various types of new crown variants.
On Weibo, Zhang Wenhong pointed out that the current round of Shanghai epidemic has entered the stage of ending the epidemic.
Zhang Wenhong said that the Omi Keron variant is a product of virus evolution.
Since the number of mutation points far exceeds all the variants that have been discovered, they should be formed after a long period of evolution in the host.
The expert said that because the Omi Keron variant carries many mutation points of the virus, it seems to have defeated other virus strains in South Africa, including the Delta strain, in a short period of time. Therefore, it should arouse great attention.
Zhang Wenhong further explained that once it is clear that the Omi Kiron strain can break through the original immune barrier, it means that we must adjust all the existing vaccine systems and begin to enter the influenza vaccination mode, which means that we must Virus mutations, rapid construction of new vaccines; also means that life will become more difficult.
Zhang Wenhong believes that China is currently in the period of strategic opportunities won by the dynamic zero-clearing strategy, and is accelerating the construction of the scientific support required to deal with the normalized anti-epidemic in the next stage, including the formation of effective vaccines and drug reserves sufficient to support the opening of the world, as well as public Reserves of health and medical resources.
(over)